# Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis

> **NCT02845934** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 248 (actual)

## Conditions studied

- Mucormycosis

## Interventions

- **OTHER:** blood sample

## Key facts

- **NCT ID:** NCT02845934
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-07
- **Final completion:** 2018-01
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2021-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02845934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02845934, "Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02845934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*